Iris Mimpen

After graduating from the Master Oncology, I joined the group of Emile Voest in February 2021. Here, my project focuses on studying the influence of the microbiome on immunotherapy efficacy and further unraveling the mechanisms underlying microbiome-mediated immune modulation.